Application Specific LC Systems
Co-Sense for Impurities - Shimadzu Corp.
The FDA draft guidance, "Genotoxic and Carcinogenic Impurities in Drug Substances and Products: Recommended Approaches" prescribes permitted limits for genotoxic impurities in drug substances. These impurities demand more sensitive trace-level analysis than normal impurities. Generally, mass spectrometry methods, such as GC/MS or LC/MS, are used for the high-sensitivity analysis of impurities. However, there is increasing demand for the establishment of a high-sensitivity quantitation method using an absorbance or other conventional detector that is easy to operate and can easily apply existing LC analysis conditions.
-
Application Specific LC Systems
Nexera MX - Shimadzu Corp.
-
Application Specific LC System
Reducing Sugar Analysis System - Shimadzu Corp.
-
Application Specific LC Systems
Nexera Amino Acid Analysis System - Shimadzu Corp.
-
Application Specific LC Systems
Nexera Organic Acid Analysis System - Shimadzu Corp.
-
Application Specific LC Systems
Method Scouting System - Shimadzu Corp.
-
Application Specific LC Systems
UF-Amino Station - Shimadzu Corp.
-
Application Specific LC Systems
Nexera-e - Shimadzu Corp.
-
Application Specific LC Systems
Nexera FV - Shimadzu Corp.
-
Application Specific LC Systems
Co-Sense Series - Shimadzu Corp.
-
Application Specific LC Systems
Co-Sense for BA (Bio-sample Analysis) - Shimadzu Corp.
-
Application Specific LC Systems
Co-Sense for LC-MS - Shimadzu Corp.
-
Application Specific LC Systems
Antimicrobial Screening System - Shimadzu Corp.
-
Application Specific LC Systems
Mycotoxin Screening System - Shimadzu Corp.